Shares of Atara Biotherapeutics Inc. (ATRA) were up more than 8% in extended trading on Thursday, following positive interim results from its ongoing phase I trial of autologous Version of ATA188 in patients with primary and secondary progressive multiple sclerosis.
from RTT - Biotech http://ift.tt/2osrE9L
via IFTTT
No comments:
Post a Comment